Biodexa Pharmaceuticals PLC Files 6-K, Incorporates Exhibits
Ticker: BDRX · Form: 6-K · Filed: Jun 13, 2024 · CIK: 1643918
| Field | Detail |
|---|---|
| Company | Biodexa Pharmaceuticals PLC (BDRX) |
| Form Type | 6-K |
| Filed Date | Jun 13, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: filing, registration-statement, administrative
Related Tickers: BDRX
TL;DR
Biodexa (BDRX) filed a 6-K, incorporating exhibits into F-3 and F-1 filings. Standard procedure.
AI Summary
Biodexa Pharmaceuticals PLC filed a Form 6-K on June 13, 2024, to incorporate by reference Exhibit 99.1 into its existing Registration Statements on Form F-3 (File No. 333-233901) and Form F-1 (File No. 333-240984). The company, formerly known as Midatech Pharma Plc, is based in Cardiff, United Kingdom.
Why It Matters
This filing is procedural, incorporating previous information into active registration statements, which is crucial for ongoing securities offerings or compliance.
Risk Assessment
Risk Level: low — This is a routine administrative filing that incorporates previously disclosed information into existing registration statements.
Key Players & Entities
- Biodexa Pharmaceuticals PLC (company) — Registrant
- Midatech Pharma Plc (company) — Former company name
- June 13, 2024 (date) — Filing date
- Form F-3 (File No. 333-233901) (document) — Incorporated registration statement
- Form F-1 (File No. 333-240984) (document) — Incorporated registration statement
FAQ
What is the purpose of this Form 6-K filing?
The purpose is to incorporate by reference Exhibit 99.1 into the Company's Registration Statements on Form F-3 (File No. 333-233901) and Form F-1 (File No. 333-240984).
When was this Form 6-K filed?
This Form 6-K was filed on June 13, 2024.
What is the principal executive office address of Biodexa Pharmaceuticals PLC?
The principal executive office is located at 1 Caspian Point, Caspian Way, Cardiff, CF10 4DQ, United Kingdom.
What was Biodexa Pharmaceuticals PLC formerly known as?
Biodexa Pharmaceuticals PLC was formerly known as Midatech Pharma Plc, with a date of name change on June 2, 2015.
Does Biodexa Pharmaceuticals PLC file annual reports under Form 20-F or Form 40-F?
Biodexa Pharmaceuticals PLC files annual reports under Form 20-F, as indicated by the checkmark in the filing.
Filing Stats: 204 words · 1 min read · ~1 pages · Grade level 11.5 · Accepted 2024-06-13 09:48:30
Filing Documents
- f6k_061324.htm (6-K) — 6KB
- exh_991.htm (EX-99.1) — 6KB
- 0001171843-24-003427.txt ( ) — 13KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Biodexa Pharmaceuticals PLC (Registrant) Date: June 13, 2024 /s/ Stephen Stamp Stephen Stamp Chief Executive Officer, Chief Financial Officer